Puradelta Lestari Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Puradelta Lestari Tbk. trades at Rp137 (market cap 6.6T, 40.24M 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp256 (market cap 715.5B, 30.64M 24h volume). The key difference: Puradelta Lestari Tbk. is far larger — about 9.2× Charlie Hospital Semarang Tbk.'s market cap, and Puradelta Lestari Tbk. is more actively traded (40.24M versus 30.64M). Which is the better fit depends on your goals.
| DMAS | RSCH | |
|---|---|---|
Market Cap | 6.6T | 715.5B |
Volume | 40.24M | 30.64M |
Lot | 402.39K | 306.41K |
Turnover | 5.52B | 7.98B |
Average Price | 137.3 | 260.34 |
Value | 5.52B | 7.98B |
Indicative Equilibrium Price | 137 | 256 |
Indicative Equilibrium Volume | 9.27K | 512 |
Trailing returns across standard periods
Latest headlines on both assets
PT Puradelta Lestari Tbk (the Company) was established in Republic of Indonesia based on Notarial Deed of Ano Muhamad Nasruddin No. 77 dated November 12, 1993, a substitute notary of Koswara, S.H., a public notary in Bandung. The Company has changed its status into Foreign Capital Investment (PMA) based on Notarial Deed No. 67 dated October 5, 1996 of Adam Kasdarmadji, S.H., a publicnotary in Jakarta.
Read more on DMAS →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →